Dosidal · Poland

pl:authorisation:100427770

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketPoland
Recordpl:authorisation:100427770 (version 1)
Levelauthorisation
Pack codenot anchored
Identifierspl-authorisation:
rpl-product-id: 100427770
Source authorityURPL
Read date
authorisation status
state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page
identityatc: L04AF03
common_name: Upadacitinibum
form: Tabletki o przedłużonym uwalnianiu
holder: AbbVie Deutschland GmbH & Co. KG
medicine: Rinvoq
procedure: CEN
routes: doustna
strength: 15 mg
substances: amount: 15
substance: Upadacitinibum
unit: mg
state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
mCOI2rnlftftw6XePm2lVfBu1KY8R-SgfNUAoZfH84TqGGfnL_hynlvRskk_JJ8Sn321llacPn7h128Bmvhp5w
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/pl:authorisation:100427770 · Same medicine in other markets · Dosidal